“I can move it,” he said defiantly, though the arm didn’t move. “I can hit pretty hard with it.”
Something the 45-year-old construction worker from Tignall received hours before could help him do that.
Woods is the second patient in a clinical trial at Georgia Health Sciences University testing whether stem cells derived from bone marrow could help patients recover from a severe stroke.
Dr. David Hess, the chairman of GHSU’s Department of Neurology, has been working with the company Athersys to help develop and test the cells, which are derived from healthy donors, tested and packaged so they can be stored in most hospital settings and given without the need to match blood type. Unlike embryonic stem cells, the cells have a very low risk of spawning a tumor, and so far they shown few side effects, Hess said.